Published in Am Rev Respir Dis on December 01, 1988
Changes in distribution, morphology, and tumor necrosis factor-alpha secretion of alveolar macrophage subpopulations during the development of bleomycin-induced pulmonary fibrosis. Am J Pathol (1992) 0.93
Regulation of T-cell proliferative responses by cells from solid lung tissue of M. tuberculosis-infected mice. Immunology (1991) 0.93
Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. Int J Exp Pathol (2001) 0.89
Minerals, fibrosis, and the lung. Environ Health Perspect (1991) 0.84
The meteorology of cytokine storms, and the clinical usefulness of this knowledge. Semin Immunopathol (2017) 0.76
Suppressive effect of TNF-alpha and IL-1 on alveolar fibroblast proliferation in sarcoidosis. Mediators Inflamm (1992) 0.75
Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol (1992) 2.33
Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes. J Immunol Methods (1983) 2.12
Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest (1990) 1.86
Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol (1987) 1.73
Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest (1984) 1.70
Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials. Ann Rheum Dis (2010) 1.58
Molecular detection of bacterial DNA in venereal-associated arthritis. Arthritis Rheum (1996) 1.55
The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood. J Immunol (1984) 1.50
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis (2011) 1.46
Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study. Ann Rheum Dis (2006) 1.42
Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial. Ann Rheum Dis (2005) 1.32
Differential interleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity. J Immunol (1985) 1.32
Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon. Biochem Biophys Res Commun (1984) 1.27
Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels. Arthritis Rheum (1986) 1.19
Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. Ann Rheum Dis (2011) 1.18
Completeness of prescription recording in outpatient medical records from a health maintenance organization. J Clin Epidemiol (1994) 1.16
Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J Clin Invest (1992) 1.11
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. Ann Rheum Dis (2010) 1.05
Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin. J Clin Invest (1988) 1.04
Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate. Ann Rheum Dis (2008) 1.00
Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis. Clin Exp Rheumatol (2010) 0.98
Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. Am Rev Respir Dis (1987) 0.96
A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord (1995) 0.93
Regulation of human lung fibroblast collagen production by recombinant interleukin-1, tumor necrosis factor, and interferon-gamma. Ann N Y Acad Sci (1990) 0.93
Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol (1994) 0.93
Breast silicone implants and risk of systemic lupus erythematosus. J Clin Epidemiol (1994) 0.92
Molecular diagnosis of Ureaplasma urealyticum septic arthritis in a patient with hypogammaglobulinemia. Arthritis Rheum (1992) 0.91
Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum (1993) 0.89
Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens. J Eur Acad Dermatol Venereol (2011) 0.88
Cerebral blood flow variations in CNS lupus. Neurology (1990) 0.87
Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum (1993) 0.86
The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. Ann Rheum Dis (2007) 0.85
Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. J Eur Acad Dermatol Venereol (2010) 0.84
Gonococcal septic arthritis of the hip. J Rheumatol (1991) 0.84
Molecular diagnosis of Borrelia burgdorferi infection (Lyme disease). DNA Cell Biol (1992) 0.83
Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy. Ann Rheum Dis (2008) 0.82
Differential prostaglandin production by unfractionated and density-fractionated human monocytes and alveolar macrophages. J Leukoc Biol (1987) 0.81
Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept. Br J Dermatol (2009) 0.81
Structural features of nephritogenic lupus autoantibodies. Methods (1997) 0.80
Comment on the 1990 American College of rheumatology criteria for fibromyalgia. Arthritis Rheum (1990) 0.80
Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial. Ann Rheum Dis (2007) 0.80
The role of fatty acid metabolites in the differentiation of the human monocyte-like cell line U937. J Leukoc Biol (1988) 0.80
Scleromyxedema with myopathy and hyperthyroidism. J Rheumatol (1996) 0.79
Transplantation of systemic sclerosis (SSc) skin grafts into severe combined immunodeficient mice: increased presence of SSc leukocytes in SSc skin grafts and autoantibody production following autologous leukocyte transfer. Pathobiology (1996) 0.79
Treatment of autoimmune disease with extracorporeal photochemotherapy: progressive systemic sclerosis. Yale J Biol Med (1990) 0.79
Fibromyalgia and parvovirus infection. Arthritis Rheum (1991) 0.79
Relapse of systemic lupus erythematosus in a patient receiving cyclosporine A. J Rheumatol (1988) 0.79
Bilateral periorbital edema in systemic lupus erythematosus. J Rheumatol (1993) 0.78
Hypertrophic osteoarthropathy as indication of aortic graft infection and aortoenteric fistula. Arch Surg (1982) 0.78
Psoriatic and seronegative inflammatory arthropathy associated with a traumatic onset: 4 cases and a review of the literature. J Rheumatol (1997) 0.78
Knee contractures as the presenting manifestation of scleroderma. Ann Rheum Dis (1992) 0.75
Eosinophilia-myalgia syndrome: selective cognitive impairment, longitudinal effects, and neuroimaging findings. J Neurol Neurosurg Psychiatry (1997) 0.75
Controlled study of sleep parameters in patients with fibromyalgia. J Clin Rheumatol (1995) 0.75
Molecular diagnosis of Borrelia burgdorferi infection (Lyme disease). DNA Cell Biol (1994) 0.75
Intravenous corticosteroid therapy of cervical cord compression in rheumatoid arthritis. Clin Exp Rheumatol (1992) 0.75
Photopheresis for scleroderma? Let's abandon the innuendos and get to the data. J Rheumatol (1993) 0.75
1,25-Dihydroxyvitamin D3 and granulomatous lesions. N Engl J Med (1985) 0.75
Lupus erythematosus arising in striae distensae. Cutis (1983) 0.75
Head and neck manifestations of eosinophilia-myalgia syndrome. Ann Otol Rhinol Laryngol (1995) 0.75
Toward rational treatment of scleroderma. Hosp Pract (Off Ed) (1993) 0.75
The role of body experience in hypnotic behavior. Int J Clin Exp Hypn (1974) 0.75